In this video, Joshua Richter, MD, Mount Sinai Medical Center, New York, NY, discusses first-line treatment options involving autologous stem cell transplant (autoSCT) for patients with multiple myeloma (MM). Dr Richter emphasizes the importance of real-world data and discusses how findings from trials can be applied in a clinical setting. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.